Explore
Validate
LearnPA5-46830
GABRP antibody from Invitrogen Antibodies
- Western blot
Supportive data in Antibodypedia
- Immunohistochemistry
- Supportive data in Antibodypedia
- Other assay
- Supportive data in Antibodypedia
Antibody data
- Antibody Data
- References [1]
- Comments [0]
- Validations
- Western blot [9]
- Immunohistochemistry [3]
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-46830
- Provider
- Invitrogen Antibodies
- Product name
- GABRP Polyclonal Antibody
- Provider product page
- Invitrogen Antibodies - PA5-46830
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Peptide sequence: VEVGRSDKLS LPGFENLTAG YNKFLRPNFG GEPVQIALTL DIASISSISE
- Concentration
- 0.5 mg/mL
GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer.
Yang Y, Ren L, Li S, Zheng X, Liu J, Li W, Fu W, Wang J, Du G
Translational cancer research 2022 Apr;11(4):649-668
Yang Y, Ren L, Li S, Zheng X, Liu J, Li W, Fu W, Wang J, Du G
Translational cancer research 2022 Apr;11(4):649-668
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human 293T whole cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human Jurkat whole cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human Jurkat cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human 293T whole cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human Jurkat whole cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human Jurkat cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human 293T whole cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human Jurkat whole cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human Jurkat cell lysate using an anti-GABRP polyclonal antibody (Product # PA5-46830).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of human heart tissue using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of human heart tissue using an anti-GABRP polyclonal antibody (Product # PA5-46830).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of human heart tissue using an anti-GABRP polyclonal antibody (Product # PA5-46830).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 GABRP mRNA expression was upregulated in pancreatic cancer. (A) The flowchart of study procedures; (B) the expression level of GABRP was measured in different types of tumor tissues and compared with normal tissues in the GEPIA2 database; (C) the expression level of GABRP was measured in different types of tumor tissues and normal tissues using the Oncomine database (P value is 0.001, fold change is 2, and gene rankings apply to all); (D) GABRP expression in tumors and matching normal tissues using two independent cohorts (GSE15471, n=78; GSE16515, n=52) derived from Gene Expression Omnibus datasets; (E) immunohistochemical analysis of GABRP expression in a human PDAC tissue microarray. Representative GABRP images are shown in the left panel. The percentages of tissues displaying low and high staining in normal pancreas and PDAC tissues are shown in the middle panel. ****, P
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 GABRP mRNA expression was upregulated in pancreatic cancer. (A) The flowchart of study procedures; (B) the expression level of GABRP was measured in different types of tumor tissues and compared with normal tissues in the GEPIA2 database; (C) the expression level of GABRP was measured in different types of tumor tissues and normal tissues using the Oncomine database (P value is 0.001, fold change is 2, and gene rankings apply to all); (D) GABRP expression in tumors and matching normal tissues using two independent cohorts (GSE15471, n=78; GSE16515, n=52) derived from Gene Expression Omnibus datasets; (E) immunohistochemical analysis of GABRP expression in a human PDAC tissue microarray. Representative GABRP images are shown in the left panel. The percentages of tissues displaying low and high staining in normal pancreas and PDAC tissues are shown in the middle panel. ****, P
